Domagk, G.: A Contribution to the Chemotherapy of Bacterial Infections, Dtsch Medizinische Wochenschrifte61 :250-253, 1935.
2.
Ehrlich, P.: Ueber Moderne Chemotherapie. In: Beitrage zur Experimentellen Pathologie und Chemotherapie, Leipzig: Akademische Verlagsgesellschaft m.b.h., 1909, pp. 167-202.
3.
Falkow, S.: Infectious Multiple Drug Resistance. London: Pion Ltd., 1975.
4.
Hughes, V.M. and Datta, N.: Conjugative Plasmids in the Bacteria of the 'Pre-antibiotic' Era, Nature302:725-726, 1983.
5.
Foster, T.J. and Kleckner, N.: Properties of Drug Resistance Transposons with Particular Reference to TnlO . In: Plasmids and Ttansposons, Stuttard, C. and Rozee, K.R., Eds., New York: Academic Press, 1980, pp. 207-227.
6.
Abraham, E.P. : The β-Lactam Antibiotics, Scientific American244(6):64, 1981.
7.
Spratt, B.G. : Penicillin Binding Proteins and the Future of β-Lactam Antibiotics, J Gen Micro129:1247-1260, 1983.
8.
Elion, G.B.: The Chemotherapeutic Exploitation of Virus Specified Enzymes, Adv Enzymol Reg18:53-66, 1980.
9.
Old, R.W. and Primrose, S.B.: Principles of Gene Manipulation. Studies in Microbiology , Vol. 2, London: Blackwell Scientific Publications, 1981.
10.
Isaacson, R.E. : Pili of Enterotoxigenic Escherichia coli, Proc . Int. Symp., Neonatal Diarrhea3:213-231, 1981.
McKay, P.; Pasek, M.; Magazin , M.; Kovacic, R.T.; Allet, B.; Stahl, S.; Gilbert, W.; Schaller, H.; Bruce, S.; and Murray, K.: Production of Immunologically Active Surface Antigens of Hepatitis B Virus by Escherichia coli, Proc Natl Acad Sci78:4510-4514, 1981 .
13.
Bittle, J.L. ; Haughton, R.A.; Alexander , H.; Shim-Mick, T.M.; Sutcliffe, J.E.; Lerner, L.A.; Rowland, D.J.; and Brown, F.: Protection against Foot-and-Mouth Disease by Immunization with a Chemically Synthesized Peptide Predicted from the Viral Nucleotide Sequence, Nature298:30-33, 1982.
14.
Jenner, E.: An Inquiry into the Causes and Effects of the Variolae Vaccinia, a Disease Discovered in some of the Western Counties of England, Particularly Gloucestershire and Known by the Name of Cow Pox. Abridged, in: Milestones in Microbiology, Brock, T. , Ed., Englewood Cliffs, NJ, and London: Prentice-Hall, Inc., 1961 , pp. 121-125.
15.
Smith, G.L. ; Mackett, M.; and Moss, B.: Infectious Vaccinia Virus Recombinants that Express Hepatitis B Virus Surface Antigen, Nature302:439-495, 1983.
16.
Kemp, D.J.; Coppel, R.L.; Cowman, A.F.; Saint, R.B.; Brown, G.V.; and Anders, R.F.: Expression of Plasmodium falciparum Blood-stage Antigens in Escherichia coli: Detection with Antibodies from Immune Humans, Proc Natl Acad Sci80:3787-3791, 1983.
17.
Germanier, R. and Fürer, E.: Isolation and Characterization of galE Mutant Ty21a of Salmonella typhi. A Candidate for a Live Oral Typhoid Vaccine, J Infect Dis131:553-558, 1975.
18.
Wahdan, M.H. ; Serie, C.; Cerisier , Y.; Sallam, S.; and Germanier, R.: A Controlled Field Trial of Live Salmonella typhi Strain Ty21a Oral Vaccine Against Typhoid. Three-year Results, J Infect Dis145:292-295, 1982.
19.
Formal, S.B. ; Baron, L.S.; Kopecko , J.; Washington, C.P.; and Life, C.A.: Construction of Potential Bivalent Vaccine Strain: Introduction of Shigella sonnei Form 1 Antigen Genes into galE Salmonella typhi Ty21a Typhoid Vaccine Strain, Infect Immun34:746-750, 1981.